Toxoplasma gondii suppress human cord blood cell differentiation to the NK cell population
Immunity, Inflammation and Disease · 2024
DOI: 10.1002/iid3.1329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Sepideh Mahmoudzadeh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Killer Cells, Natural, Fetal Blood, Cell Differentiation, Toxoplasma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Immunology Research Center and School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract (Originalsprache)
Background
Toxoplasma gondii is an obligate intracellular protozoan parasite that can invade all mammalian cells. It is well established that natural killer (NK) cells have critical protective roles in innate immunity during infections by intracellular pathogens. In the current study, we conducted an in vitro experiment to evaluate NK cell differentiation and activation from human umbilical cord blood mononuclear cells (UCB‐MNCs) after infection with T. gondii tachyzoites.
Methods
UCB‐MNCs were infected by fresh tachyzoites of type I (RH) or type II (PTG) strains of T. gondii pre‐expanded in mesenchymal stem cells for 2 weeks in a medium enriched with stem cell factor, Flt3, IL‐2, and IL‐15. Flow cytometry analysis and western blot analysis were performed to measure the CD57 + , CD56 + , and Granzyme A (GZMA).
Results
Data revealed that incubation of UCB‐MNCs with NK cell differentiation medium increased the CD57 + , CD56 + , and GZMA. UCB‐MNCs cocultured with PTG tachyzoites showed a significant reduction of CD56 + and GZMA, but nonsignificant changes, in the levels of CD56 + compared to the control UCB‐MNCs ( p > .05). Noteworthy, 2‐week culture of UCB‐MNCs with type I (RH) tachyzoites significantly suppressed CD57 + , CD56 + , and GZMA, showing reduction of NK cell differentiation from cord blood cells.
Conclusion
Our findings suggest that virulent T. gondii tachyzoites with cytopathic effects inhibit NK cell activation and eliminate innate immune responses during infection, and consequently enable the parasite to continue its survival in the host body.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Parasitology and Mycology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Histopathology and Anatomy, Faculty of Medical Sciences, Tabriz Medical Sciences, Islamic Azad University, Tabriz, Iran.
- Department of Applied Cell Sciences, Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Sarab Faculty of Medicine, Sarab, Iran.
ORCID-Profile: Ehsan Ahmadpour
Förderung
- Immunology Research Center and School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Zitieren
APA
Mahmoudzadeh, S., Dizaji Asl, K., Nozad Charoudeh, H., Rahbarghazi, R., Ahmadi, M., Heidarzadeh, M., Spotin, A., & Ahmadpour, E. (2024). Toxoplasma gondii suppress human cord blood cell differentiation to the NK cell population. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1329
Vancouver
Mahmoudzadeh S, Dizaji Asl K, Nozad Charoudeh H, Rahbarghazi R, Ahmadi M, Heidarzadeh M, et al. Toxoplasma gondii suppress human cord blood cell differentiation to the NK cell population. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.1329
BibTeX
@article{Mahmoudzadeh2024,
author = {Mahmoudzadeh, Sepideh and Dizaji Asl, Khadijeh and Nozad Charoudeh, Hojjatollah and Rahbarghazi, Reza and Ahmadi, Mahdi and Heidarzadeh, Morteza and Spotin, Adel and Ahmadpour, Ehsan},
title = {Toxoplasma gondii suppress human cord blood cell differentiation to the NK cell population},
journal = {Immunity, Inflammation and Disease},
year = {2024},
doi = {10.1002/iid3.1329}
}
EUVIMED